TITLE

2008 - Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease

AUTHOR(S)
Rees, P. John
PUB. DATE
March 2009
SOURCE
ACP Journal Club;3/17/2009, Vol. 150 Issue 3, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article deliberates on the harms and benefits of inhaled corticosteroid (ICS) therapy in patients with stable chronic obstructive pulmonary disease (COPD). Research conducted reveals that ICS therapy does not reduce mortality but increases risk for pneumonia in COPD patients. However, ICSs remain a useful treatment for patients with moderately severe COPD and troublesome exacerbations despite long-acting beta-agonist (LABA) and/or tiotropium therapy.
ACCESSION #
38421570

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics